Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous
Diltiazem Hydrochloride
Diltiazem Hydrochloride
0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US1 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
30
Rx · 2025 Q4
72
Units dispensed
4
Quarters · since 2025 Q1
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hospira, Inc. | unknown | 1 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 5, 2026RESOLVEDShortage resolved: Diltiazem Hydrochloride Injection (Hospira, Inc., a Pfizer Company)
Diltiazem Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.
- Jan 5, 2026SHORTAGEDrug shortage: Diltiazem Hydrochloride Injection (Hospira, Inc., a Pfizer Company)
Diltiazem Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.
Pill